SARS-CoV-2 triggering autoimmune diseases

被引:61
|
作者
Mobasheri, Leila [1 ]
Nasirpour, Mohammad Hossein [2 ]
Masoumi, Elham [3 ,4 ]
Azarnaminy, Afsaneh Foolady [5 ]
Jafari, Mozhdeh [6 ,7 ]
Esmaeili, Seyed-Alireza [6 ,7 ]
机构
[1] Mashhad Univ Med Sci, Fac Med, Dept Pharmacol, Mashhad, Razavi Khorasan, Iran
[2] Natl Inst Genet Engn & Biotechnol NIGEB, Inst Med Biotechnol, Dept Med Genet, Tehran, Iran
[3] Ilam Univ Med Sci, Sch Med, Dept Immunol, Ilam, Iran
[4] Ilam Univ Med Sci, Sch Med, Student Res Comm, Ilam, Iran
[5] Social Secur Org Hosp, Dept Anesthesiol, Ardebil, Iran
[6] Mashhad Univ Med Sci, Immunol Res Ctr, Mashhad, Razavi Khorasan, Iran
[7] Mashhad Univ Med Sci, Fac Med, Immunol Dept, Mashhad, Razavi Khorasan, Iran
关键词
SARS-CoV-2; Covid-19; Autoimmune disease; Autoimmunity; Cytokine; MOLECULAR MIMICRY; TOLEROGENIC PROBIOTICS; CLINICAL-FEATURES; MYASTHENIA-GRAVIS; T-CELLS; COVID-19; IMMUNOPATHOGENESIS; PATHOGENESIS; VACCINATION; EXPRESSION;
D O I
10.1016/j.cyto.2022.155873
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autoimmunity, hyperstimulation of the immune system, can be caused by a variety of reasons. Viruses are thought to be important environmental elements that contribute to the development of autoimmune antibodies. It seems that viruses cause autoimmunity with mechanisms such as molecular mimicry, bystander activation of T cells, transient immunosuppression, and inflammation, which has also been seen in post-Covid-19 autoimmunity. Infection of respiratory epithelium by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) dysregulates the immune response, triggers both innate and acquired immunity that led to the immune system's hyperactivation, excessive cytokine secretion known as "cytokine storm, " and finally acute respiratory distress syndrome (ARDS) associated with high mortality. Any factor in the body that triggers chronic inflammation can contribute to autoimmune disease, which has been documented during the Covid-19 pandemic. It has been observed that some patients produce autoantibody and autoreactive CD4(+) and CD8(+) T cells, leading to the loss of self-tolerance. However, there is a scarcity of evidence defining the precise molecular interaction between the virus and the immune system to elicit autoreactivity. Here, we present a review of the relevant immunological findings in Covid-19 and the current reports of autoimmune disease associated with the disease.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Autoimmune liver diseases and SARS-CoV-2
    Sgamato, Costantino
    Rocco, Alba
    Compare, Debora
    Minieri, Stefano
    Marchitto, Stefano Andrea
    Maurea, Simone
    Nardone, Gerardo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (12) : 1838 - 1851
  • [2] Autoimmune liver diseases and SARS-CoV-2
    Costantino Sgamato
    Alba Rocco
    Debora Compare
    Stefano Minieri
    Stefano Andrea Marchitto
    Simone Maurea
    Gerardo Nardone
    World Journal of Gastroenterology, 2023, (12) : 1838 - 1851
  • [3] SARS-CoV-2 infection in patients with systemic autoimmune diseases
    Brito-Zeron, P.
    Siso-Almirall, A.
    Flores-Chavez, A.
    Retamozo, S.
    Ramos-Casals, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (03) : 676 - 687
  • [4] SARS-CoV-2 infection among patients with systemic autoimmune diseases
    Emmi, Giacomo
    Bettiol, Alessandra
    Mattioli, Irene
    Silvestri, Elena
    Di Scala, Gerardo
    Urban, Maria Letizia
    Vaglio, Augusto
    Prisco, Domenico
    AUTOIMMUNITY REVIEWS, 2020, 19 (07)
  • [5] Considerations on SARS-CoV-2 vaccines in patients with autoimmune blistering diseases
    Cozzani, Emanuele
    Gasparini, Giulia
    Sticchi, Laura
    Russo, Roberto
    Icardi, Giancarlo
    Parodi, Aurora
    EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31 (03) : 415 - 417
  • [6] A Review Pertaining to SARS-CoV-2 and Autoimmune Diseases: What Is the Connection?
    Kocivnik, Nina
    Velnar, Tomaz
    LIFE-BASEL, 2022, 12 (11):
  • [7] SARS-CoV-2 infection and its prevention in pediatric autoimmune diseases
    Tamas, Constantin
    Andrea, Kulcsar
    Peter, Krivacsy
    Zsofia, Meszner
    Andrea, Ponyi
    Attila, Toth
    Beata, Onozo
    Zoltan, Szekanecz
    ORVOSI HETILAP, 2022, 163 (11) : 414 - 423
  • [8] Considerations on SARS-CoV-2 vaccines in patients with autoimmune blistering diseases
    Emanuele Cozzani
    Giulia Gasparini
    Laura Sticchi
    Roberto Russo
    Giancarlo Icardi
    Aurora Parodi
    European Journal of Dermatology, 2021, 31 : 415 - 417
  • [9] SARS-CoV-2, the autoimmune virus
    Halpert, Gilad
    Shoenfeld, Yehuda
    AUTOIMMUNITY REVIEWS, 2020, 19 (12)
  • [10] SARS-CoV-2 and Autoimmune Cytopenia
    Quinn, Ryann
    Murakhovskaya, Irina
    HEMATO, 2021, 2 (03): : 463 - 476